Enzo Biochem, Inc. (NYSE:ENZ)

CAPS Rating: 2 out of 5

The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.

Recs

0
Player Avatar Boum (< 20) Submitted: 8/22/2009 10:23:07 AM : Outperform Start Price: $4.63 ENZ Score: -92.18

What do you think, is this company good manged ?
When I read other pitch it seem not. But I think earning money is not the goal.
They are building knowledge for future...
The stock is cheap, potential high and when other pharmaceutic company will have cash again...

Featured Broker Partners


Advertisement